Last updated: June 5, 2026

Back to directory

MVision Contour+ medical AI product profile

Radiotherapy auto-contouring software that generates CT and MR segmentation templates for trained clinicians to review, edit, and approve.

Screenshot of the official MVision Contour+ product page
Medical imaging and radiology

Best fit

Radiation oncology programs that want guideline-based segmentation coverage across major anatomical sites and can commission local clinician-review workflows.

Primary use case
AI-powered auto-contouring, guideline-based organ-at-risk and lymph-node segmentation, CT and MR contour templates, and treatment-planning workflow acceleration
Audience
Radiation oncology departments, dosimetrists, medical physicists, treatment-planning teams, and oncology AI governance committees
Risk level
High
Pricing signal
Enterprise radiotherapy pricing; verify current Contour+, GBS, Workspace+, deployment model, support, and regional availability.
Official sources
4 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating MVision Contour+ as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as high-risk radiotherapy image-analysis software and verify the exact FDA record, version, CT/MR scope, anatomy, intended users, and real-time adaptive planning exclusions.
PrivacyReview cloud versus local deployment, DICOM transfer, pseudonymization, TLS encryption, support access, retention, BAA terms, and whether images or contours are reused for model development.
EvidenceCommission by cancer site, scanner, CT and MR protocol, contouring guideline, outlier anatomy, edit burden, and plan-quality impact before relying on vendor time-saving claims.
WorkflowBest governed as an initial contour-template generator with radiation oncologist review, dosimetrist editing, physicist QA, exception handling, and fallback manual contouring.

Where MVision Contour+ fits

MVision describes Contour+ as AI-powered radiotherapy auto-segmentation for organs-at-risk and lymph-node areas, delivered through Workspace+ and GBS workflows; FDA summaries for Contour+ state that CT and MR contours are initial templates that qualified professionals must visualize, review, modify, and approve before clinical use.

Not for: Lesion or tumor detection, real-time adaptive planning, unreviewed contour acceptance, or use outside the currently cleared modality, anatomy, geography, and labeling.

What to verify before using MVision Contour+

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products